Clinical Trial Update: NeoVax With Nivolumab in Patients With Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating NeoVax in combination with nivolumab for ovarian cancer is currently active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• NeoVax
• nivolumab (nivolumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING